Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 36 min ago
Peer-reviewedCC BY 4.0Endoscopy International Open

Endoscopic Retrograde Cholangiopancreatography in Pediatric Pancreas Divisum: Systematic Review

3 more authors
10 affiliations
  1. 1Internal Medicine AdventHealth Orlando Orlando Florida United States
  2. 2Advanced Endoscopy Houston Methodist Houston Texas United States
  3. 3Internal Medicine Brigham and Women’s Hospital Boston Massachusetts United States
  4. 4Advanced Endoscopy Loma Linda University Health Loma Linda California United States
  5. 5Center for Interventional Endoscopy AdventHealth Orlando Orlando Florida United States
  6. 6Advanced Endoscopy University of Iowa Iowa City Iowa United States
  7. 7Center for Interventional Endoscopy AdventHealth Central Florida Orlando Florida United States
  8. 8Center For Interventional Endoscopy AdventHealth Orlando Orlando Florida United States
  9. 9Department of Pediatric Gastroenterology Texas Children’s Hospital West Campus Houston Texas United States
  10. 10Center for Interventional Gastroenterology at UTHealth University of Texas McGovern Medical School Houston Texas United States

Abstract

Background Pancreas divisum (PD) may be associated with recurrent acute pancreatitis (RAP) or chronic pancreatitis (CP), but data on ERCP outcomes in children with PD are limited. We conducted a systematic review of the clinical, technical, and safety outcomes of ERCP for PD in children.

Materials and Methods Multiple databases were searched through May 2025. The primary outcome was clinical response, as defined by each individual study; secondary outcomes were symptom resolution, technical success, and post-ERCP pancreatitis (PEP). Because outcome definitions and interventions varied and no study included a control group, outcomes were summarized narratively and were not pooled.

Results Eight retrospective studies including 247 patients were included. Clinical response ranged from 65.0 to 93.3% across six studies, symptom resolution from 19.1 to 54.1%, and technical success from 77.8 to 100%. Reported PEP ranged from 7.9 to 20.7%, with mixed patient and procedure denominators. Response ranged from 80.0 to 100% in RAP and 60.0 to 87.9% in CP, and was higher in RAP in three of four studies reporting both. Outcome definitions differed for every outcome examined.

Conclusions The available pediatric literature cannot establish whether ERCP is effective in children with PD. Every study was uncontrolled and retrospective, and outcome definitions were not comparable. The reported clinical response was frequent, particularly in RAP, but may in part reflect regression to the mean, and the PEP risk warrants caution. Given the low certainty of evidence and risk of adverse events, in particular PEP, further prospective studies are needed to define the role of ERCP in this population. A core set of outcome definitions and prospective controlled studies are required to determine efficacy.

Related

  1. Successful gel-immersion cannulation of hepaticojejunostomy during enteroscopy-assisted endoscopic retrograde cholangiopancreatography
    Shintaro Kawasaki, Atsuto Kayashima, Haruka Okada +4
    EndoscopyPeer-reviewedCC BY 4.0Full textGeneral medicinePMC
  2. Breaking the compatibility barrier: cholangioscopy-guided laser lithotripsy during enteroscopy-assisted endoscopic retrograde cholangiopancreatography in Roux-en-Y anatomy.
    Alda Andrade, Ana Rita Ribeiro, Jorge Bezerra +4
    EndoscopyPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  3. Safety and Recovery Profile of Propofol-Based Intravenous Sedation for Endoscopic Retrograde Cholangiopancreatography in Adults: A Prospective Single-Center Observational Study
    Muhammad Ahmad Khan, Tariq Mahmood, Mirza Ahmad Raza Baig +2
    CureusPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  4. Cerebral Air Embolism Following Endoscopic Retrograde Cholangiopancreatography Stent Removal: A Rare and Fatal Complication.
    Bavani Senthuran, A Arulmurali, Anuratha Kajendran +2
    Case reports in anesthesiologyPeer-reviewedCC BYFull textGeneral medicineEurope PMCPMC
  5. Curated endoscopic retrograde cholangiopancreatography images dataset
    Alda João Andrade, Mónica Martins, André Ferreira +3
    Scientific DataPeer-reviewedCC BY-NC-ND 4.0Full textGeneral medicinePMC
BibTeX
@article{alsaleh2026endoscopic,
  title = {{Endoscopic Retrograde Cholangiopancreatography in Pediatric Pancreas Divisum: Systematic Review}},
  author = {Tareq Alsaleh and Saurabh Chandan and Shahab R. Khan and Sagar Pathak and Abdul Mohammed and Abdullah Abbasi and Maham Hayat and Natalie Cosgrove and Deepanshu Jain and Kambiz Kadkhodayan and Dennis Yang and Ojasvini C. Chandan and Muhammad K. Hasan and John George and Mustafa A. Arain},
  journal = {Endoscopy International Open},
  year = {2026},
  month = oct,
  doi = {10.1055/a-2977-6424},
  url = {https://doi.org/10.1055/a-2977-6424},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Endoscopic Retrograde Cholangiopancreatography in Pediatric Pancreas Divisum: Systematic Review
AU  - Tareq Alsaleh
AU  - Saurabh Chandan
AU  - Shahab R. Khan
AU  - Sagar Pathak
AU  - Abdul Mohammed
AU  - Abdullah Abbasi
AU  - Maham Hayat
AU  - Natalie Cosgrove
AU  - Deepanshu Jain
AU  - Kambiz Kadkhodayan
AU  - Dennis Yang
AU  - Ojasvini C. Chandan
AU  - Muhammad K. Hasan
AU  - John George
AU  - Mustafa A. Arain
PY  - 2026
DA  - 2026/10/27
JO  - Endoscopy International Open
DO  - 10.1055/a-2977-6424
UR  - https://doi.org/10.1055/a-2977-6424
AB  - Background Pancreas divisum (PD) may be associated with recurrent acute pancreatitis (RAP) or chronic pancreatitis (CP), but data on ERCP outcomes in children with PD are limited. We conducted a systematic review of the clinical, technical, and safety outcomes of ERCP for PD in children.  Materials and Methods Multiple databases were searched through May 2025. The primary outcome was clinical response, as defined by each individual study; secondary outcomes were symptom resolution, technical success, and post-ERCP pancreatitis (PEP). Because outcome definitions and interventions varied and no study included a control group, outcomes were summarized narratively and were not pooled.  Results Eight retrospective studies including 247 patients were included. Clinical response ranged from 65.0 to 93.3% across six studies, symptom resolution from 19.1 to 54.1%, and technical success from 77.8 to 100%. Reported PEP ranged from 7.9 to 20.7%, with mixed patient and procedure denominators. Response ranged from 80.0 to 100% in RAP and 60.0 to 87.9% in CP, and was higher in RAP in three of four studies reporting both. Outcome definitions differed for every outcome examined.  Conclusions The available pediatric literature cannot establish whether ERCP is effective in children with PD. Every study was uncontrolled and retrospective, and outcome definitions were not comparable. The reported clinical response was frequent, particularly in RAP, but may in part reflect regression to the mean, and the PEP risk warrants caution. Given the low certainty of evidence and risk of adverse events, in particular PEP, further prospective studies are needed to define the role of ERCP in this population. A core set of outcome definitions and prospective controlled studies are required to determine efficacy.
SN  - 2364-3722
SN  - 2196-9736
ER  -